Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France

• Main Authors: Perrine Roux (Author), Daniela Rojas Castro (Author), Khadim Ndiaye (Author), Laélia Briand Madrid (Author), Virginie Laporte (Author), Marion Mora (Author), Gwenaelle Maradan (Author), Stéphane Morel (Author), Bruno Spire (Author), Patrizia Carrieri (Author)
• Format: Book
• Published: BMC, 2017-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Injectable opioids are an interesting option for people who inject drugs (PWID) that do not respond to oral Opioid Maintenance Treatment (OMT). To date, intravenous (IV) buprenorphine - a safer drug than full-opioid agonists in terms of overdose risk - has never been tested in a...